Can Supraventricular Tachycardia Be Deadly?
Yes, supraventricular tachycardia can be life-threatening, though it rarely causes death in most patients. The risk of mortality depends critically on specific patient characteristics and the underlying mechanism of the arrhythmia.
Risk Stratification: Who Is at Risk?
Low-Risk Patients (Mortality ~1%)
In otherwise healthy adults without structural heart disease, SVT is rarely life-threatening 1. The 2019 ESC Guidelines explicitly state that "unlike ventricular tachycardia, they are rarely life-threatening" in the general population 1. However, even in this low-risk group, approximately 5% of patients presenting with aborted sudden death had SVT as the underlying cause 2.
High-Risk Populations
Neonates and infants face significantly higher mortality risk:
- Overall case fatality: 3-4% 3
- Risk factors for fatal outcome include:
Patients with structural heart disease have 6-fold higher mortality compared to 1% in those without structural disease 4. The presence of cardiomyopathy increases risk dramatically (OR 6.72-6.74) 4.
Adults with congenital heart disease face increased risk of heart failure, stroke, and sudden cardiac death when SVT is untreated 1.
Life-Threatening Mechanisms
Direct Mechanisms Leading to Death
Pre-excited atrial fibrillation in Wolff-Parkinson-White syndrome: This represents the most dangerous scenario where rapid conduction over an accessory pathway can degenerate into ventricular fibrillation 5, 2. The 2016 ACC/AHA/HRS Guidelines emphasize that "the resulting fast, often irregular, broad-complex tachycardia is often unstable and may lead to ventricular fibrillation" 5.
Degeneration to ventricular fibrillation: Approximately 5% of aborted sudden death cases are caused by SVT deteriorating into ventricular fibrillation 2. This occurs through:
Cardiogenic shock: Rapid SVT can cause hemodynamic collapse, particularly in patients with severe dilated or hypertrophic cardiomyopathy 6.
Indirect Mechanisms
Untreated SVT can result in:
- Heart failure 1
- Pulmonary edema 1
- Myocardial ischemia secondary to increased heart rate 1
- Tachycardia-induced cardiomyopathy (which may be reversible) 6
Treatment-Related Mortality Risk
Proarrhythmia from antiarrhythmic drugs poses significant risk, especially in neonates 3. Class IC antiarrhythmics caused proarrhythmia in 50% of cases where it occurred, with detection being "especially difficult in neonates because of their narrow QRS" 3. Digoxin and amiodarone also contributed to proarrhythmic events 3.
Critical Clinical Pitfalls
Never use AV nodal blocking agents (verapamil, diltiazem, beta-blockers, adenosine, digoxin) in pre-excited atrial fibrillation—these can accelerate ventricular rates and precipitate ventricular fibrillation 5.
Adenosine itself can precipitate atrial fibrillation that may conduct rapidly in patients with accessory pathways, potentially causing ventricular fibrillation 5. Electrical cardioversion must be immediately available when using adenosine.
Hemodynamically unstable patients require immediate synchronized cardioversion, not pharmacological trials 5.
Contemporary Evidence on Unstable SVT
The most recent 2025 multicenter study challenges traditional approaches: In unstable SVT patients, electrical cardioversion had superior success rates (OR 2.41) compared to adenosine, though adenosine may be attempted first as it avoids sedation-related risks 7. Importantly, no complications occurred in either group in this real-world prehospital study 7.
Bottom Line Algorithm
For stable patients without pre-excitation: Mortality risk is <1%; vagal maneuvers followed by adenosine is appropriate.
For patients with known WPW and atrial fibrillation: This is a medical emergency requiring immediate cardioversion—mortality risk from ventricular fibrillation is substantial 5, 2.
For hemodynamically unstable patients: Immediate synchronized cardioversion is mandatory regardless of mechanism 5.
For neonates/infants or patients with structural heart disease: Mortality risk is 3-6%; aggressive monitoring for proarrhythmia and complications is essential 3, 4.